Get the Daily Brief
Latest Biotech News
Genomic AI Advances: Pharma Collaboration and Novel Protein Designs
Pharmaceutical companies including AbbVie, Johnson & Johnson, Bristol Myers Squibb, Takeda, and Otsuka’s Astex Pharmaceuticals have pooled proprietary structural data of thousands of...
Spatial Proteomics Technologies Accelerate Molecular Insights in Cancer and Beyond
Innovations in spatial proteomics are enabling unprecedented molecular mapping within tissues, critical for understanding diseases like cancer. The GeoMx Discovery Proteome Atlas (DPA) expands...
FDA Actions Mark Regulatory Challenges and Approvals Amid US Government Shutdown
The US government shutdown has interrupted FDA operations, halting new drug and biologic submissions requiring user fees and delaying regulatory decisions. Recent developments include the FDA’s...
Groundbreaking Method Creates Fertilizable Human Eggs from Skin Cells
Scientists at Oregon Health & Science University achieved a pioneering milestone by generating fertilizable eggs from human skin cells in vitro. Using somatic cell nuclear transfer (SCNT) combined...
Merus Acquisition by Genmab Validates Bispecific Antibody Potential in Oncology
Genmab announced its largest acquisition, purchasing Merus for approximately $8 billion in cash. The deal centers on Merus’s lead asset, petosemtamab, an EGFRxLGR5 bispecific antibody with...
Advances in Rapid Whole-Genome Sequencing for Rare Disease Applications
Oxford Nanopore Technologies introduced a 24-hour rapid whole-genome sequencing (WGS) workflow specifically targeting rare disease research, particularly in critical care scenarios like neonatal...
Early Clinical and Scientific Insights into Emerging Therapeutics and Diagnostic Technologies
The oncology and biotech landscape saw notable progress including the ongoing clinical development of Cartography Biosciences’ colorectal cancer targeted therapies supported by a recent $67...
Psilocybin Eases Chronic Pain and Depression in Preclinical Models
Researchers at the University of Pennsylvania demonstrated that a single dose of psilocybin in mouse models reduced both chronic pain and associated depressive and anxiety-like behaviors. The...
Deep Visual Proteomics Unlocks Treatment Pathways for Toxic Epidermal Necrolysis
A Max Planck Institute team applied deep visual proteomics, combining imaging, machine learning, and mass spectrometry, to analyze toxic epidermal necrolysis (TEN) at a spatial proteome level....
Mass Spectrometry Maps Protein Localization Changes in Viral Response
Scientists at Chan Zuckerberg Biohub developed a mass spectrometry–based method to spatially map the subcellular localization of proteins, revealing dynamic relocalization during viral infection....
Advanced AI Enables Synthetic Proteins Outperforming Natural Genome Editors
Researchers at Integra Therapeutics along with Pompeu Fabra University and the Center for Genomic Regulation have designed synthetic proteins via generative AI that exceed natural proteins in...
Takeda Exits Cell Therapy Research to Refocus Pipeline Priorities
Japanese pharmaceutical giant Takeda announced the discontinuation of all cell therapy research activities, including platform technologies and clinical-stage programs, as part of a strategic...
Amgen’s PCSK9 Inhibitor Demonstrates Expanded Primary Prevention Benefits
Amgen presented landmark clinical trial data indicating its cholesterol-lowering drug Repatha reduces risk of major cardiovascular events in patients without prior cardiovascular disease. The...
Spatial Multiomics Tools and Software Propel Cancer and Disease Research
Researchers from Mount Sinai, Boston Medical Center, and Boston University unveiled Giotto Suite, an integrated software ecosystem designed to analyze complex spatial multiomics data, including...
AI-Driven Diagnostic and Drug Discovery Advances in Biopharma
Biopharmaceutical companies are harnessing AI to accelerate drug discovery and optimize diagnostics. A collaboration including AbbVie, Johnson & Johnson, Bristol Myers Squibb, Takeda, and Astex...
NIH and Academic Initiatives Push Pediatric and Rare Disease Research
Significant NIH funding supports novel pediatric research efforts including Pop Biotechnologies’ Alzheimer’s immunotherapy development and large-scale newborn genomic screening initiatives aimed...
Vanda Pharmaceuticals and FDA Resolve Legal Disputes Amid Drug Re-evaluations
Following protracted legal confrontations, Vanda Pharmaceuticals has agreed to withdraw or suspend multiple lawsuits against the FDA in return for re-examinations of two candidate treatments for...
Pfizer, Trump Reach Most-Favored Nation Drug Pricing Deal Amid Industry Adjustments
In a pivotal move, Pfizer has agreed to price newly launched drugs at parity with prices in comparable developed nations under a most-favored nation pricing agreement negotiated with the Trump...
Takeda Exits Cell Therapy Research to Refocus on Transformative Therapeutics
Japanese pharmaceutical giant Takeda has announced the discontinuation of all cell therapy research efforts as part of a strategic portfolio prioritization. The company plans to seek external...
Innovative AI Models Enhance Protein Design and Drug Discovery Collaborations
Recent breakthroughs reveal the use of advanced artificial intelligence models in protein engineering and drug discovery. Researchers at Integra Therapeutics, in partnership with academic...